SB 742, the "Maryland Protecting People With Disabilities Act," modifies Maryland’s Medicaid eligibility processes to better protect individuals with disabilities who receive home- and community-based services. It extends the appeal timeframe for those losing eligibility and requires services to continue uninterrupted during appeals, preventing administrative errors from causing abrupt service loss. The bill prohibits "procedural disenrollment" (terminating coverage due to renewal process issues) and mandates the Department of Health to reserve waiver slots for people who lost eligibility unfairly. These changes align with the Olmstead decision, ensuring individuals can remain in community settings without unnecessary bureaucratic barriers. The bill directly affects Maryland Medicaid recipients with disabilities who rely on home- and community-based services.
HB 1377 establishes a 18-month pilot program to redirect unused, unopened prescription drugs to a state repository program. It requires participating pharmacies (repositories) to collect eligible medications during National Prescription Drug Take Back Days, package them properly, and transfer them to designated drop-off sites for distribution to eligible patients - while sending controlled substances directly to the DEA. The program aims to expand medication access for underserved communities, reduce pharmaceutical waste, and ensure drug safety through collaboration between Maryland’s Secretary of Health and the federal DEA. The pilot runs from July 2026 through December 2027, with mandatory reporting on collected medications by October 1, 2027.
HB 1376 requires Maryland's Medicaid (Maryland Medical Assistance Program) and Children's Health Program to provide a review within 3 business days for transfer requests to special pediatric hospitals when requested by the hospital or referring provider. It mandates retrospective reviews if a transfer is denied as "not medically necessary," with providers reimbursed for "administrative days" (days a patient remains without transfer) during the review process. The bill directly affects special pediatric hospitals - facilities serving children under 22 or those 2+ years old with co-occurring physical/behavioral health conditions - and their referring providers. Key provisions include eliminating prior authorization requirements for transfers while establishing strict timelines and reimbursement for administrative delays during appeals. This bill updates existing Medicaid and insurance rules to streamline transfers to specialized pediatric care facilities.
SB 772 requires the Maryland Department of Health to create and maintain a public database of employment training and job placement programs. The database will help residents find opportunities that can lead to eligibility for Medicaid (Maryland Medical Assistance Program) and SNAP (Supplemental Nutrition Assistance Program), including program details, application steps, and direct contact options. The Department must update the database every 30 days and assist individuals in enrolling in listed programs. Other state agencies, including the Department of Labor and Department of Human Services, must recommend programs for inclusion. This bill directly affects Maryland residents seeking to improve employment prospects while maintaining access to critical health and nutrition benefits.
This bill prohibits insurers, nonprofit health plans, and health maintenance organizations from denying emergency room coverage solely because a patient did not experience a diagnosed emergency medical condition. It requires two key studies: one to quantify hospital and post-acute care bed capacity across Maryland, and another to identify ways to improve transitions from emergency to post-acute care settings. These provisions directly affect patients receiving emergency care and healthcare providers treating them, ensuring coverage isn't denied based on diagnosis alone. The studies aim to inform data-driven recommendations for future policy improvements in emergency and post-acute care access.
HB 1016 invalidates noncompete and conflict-of-interest clauses in employment contracts for certain employees if their employer relocates the majority of its employees or principal business location outside Maryland. It directly affects low-wage workers (earning ≤150% of state minimum wage), healthcare workers providing direct patient care (earning ≤$350,000 annually), and veterinary professionals. For high-earning healthcare workers ($350,000+), the bill allows limited 1-year noncompete restrictions within 10 miles of their prior workplace. The law takes effect October 1, 2026, and applies only to contracts signed after that date.
SB 579 requires Maryland counties with volunteer fire companies to provide no-cost preventive cancer screenings to volunteer firefighters, based on guidelines from the International Association of Fire Fighters. Volunteer fire companies must maintain and annually submit updated lists of their members to the county, which must then keep these records. Counties can meet this requirement by offering annual exams including cancer screenings or applying for specific grants to fund innovative screening technologies. The bill directly affects volunteer firefighters and counties, creating a structured process for access to preventive care without cost to the firefighters.
HB 1012 authorizes counties and municipalities in Maryland to establish local suicide fatality review teams, which directly affect local governments and public health agencies. These teams must include representatives from health departments, law enforcement, schools, hospitals, and mental health professionals to review suicide cases and identify systemic factors. The bill requires teams to coordinate with the state suicide review committee and mandates confidentiality for case discussions, exempting meetings about individual cases from public disclosure laws and protecting sensitive information. It also prohibits public disclosure of identifying details about deceased individuals or those affected by suicide, ensuring privacy while allowing teams to develop prevention recommendations.
SB 719 restricts the land application of sewage sludge containing per- and polyfluoroalkyl substances (PFAS) above specific concentration levels, effective after a set date. It requires monitoring for PFAS in sewage sludge and products containing it, authorizes stricter pretreatment rules for industrial users discharging PFAS, and allows local jurisdictions to set fees for such discharges. The bill directly affects sewage sludge generators (like wastewater treatment facilities), industrial users, and local regulators by mandating new PFAS testing, usage limits, and fee structures. It amends Maryland’s environmental code to establish these requirements without changing existing land application rules for sludge below the new PFAS thresholds.
SB 707 amends Maryland's Mental Health Law to clarify the definition of "danger to the life or safety of the individual or of others" for involuntary admission and emergency evaluations. It specifies that this danger includes four key scenarios: causing bodily harm, engaging in conduct likely to result in criminal justice involvement, inability to meet basic needs (food, shelter, medical care) creating serious risk, or substantial deterioration in judgment preventing informed treatment decisions. The bill directly affects individuals with mental disorders who may be assessed for involuntary care, as well as healthcare providers making those determinations under the law. This definition replaces the current standard in Maryland Code, Section 10-601, and takes effect October 1, 2026.
